Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Long-term cardiac impact of Japan quake revealed

The 2011 earthquake and tsunami that devastated parts of north-eastern Japan led to a significantly increased weekly occurrence of cardiovascular disease in the months after the event, study findings show.

5 Sep 2012

Study evaluates prognostic utility of novel biomarkers of cardiovascular stress

Critical Diagnostics announced today, Circulation, an American Heart Association Journal, released online the first study evaluating the power of ST2 to predict development of heart failure and other adverse outcomes in the general population titled, "Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study".

5 Sep 2012

Green tea chemical found to boost memory

It has long been believed that drinking green tea is good for the memory. Now researchers have discovered how the chemical properties of China’s favorite drink affect the generation of brain cells, providing benefits for memory and spatial learning. The research is published in Molecular Nutrition & Food Research.

5 Sep 2012

Motor coordination in children with sedentary lifestyles: an interview with Dr. Luis Lopes

The importance of an adequate motor coordination level in childhood has recently reemerged. In literature on motor skill development, the focus is mostly on the proficiency/competence level in movement skills. Motor competence/coordination can be defined as a person’s ability to execute different motor acts, including coordination of both fine and gross motor skills (Henderson & Sugden, 1992).

4 Sep 2012

Lack of evidence to recommend routine screening for chronic kidney disease

Currently there is insufficient evidence to recommend the routine screening of chronic kidney disease in asymptomatic adults in the general population, according to a review by the US Preventive Services Task Force.

4 Sep 2012

Exposure to perfluorooctanoic acid appears to increase risk of CVD and peripheral arterial disease

Exposure to perfluorooctanoic acid (PFOA), a manmade chemical used in the manufacture of some common household products, appears to be associated with cardiovascular disease and peripheral arterial disease in a study of 1,216 individuals, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.

4 Sep 2012

Low blood pressure increases diabetes mortality risk

Tight blood pressure control fails to confer a survival benefit in patients newly diagnosed with Type 2 diabetes, and may even increase mortality risk when low blood pressure levels are achieved, UK investigators have discovered.

3 Sep 2012

Heart rate marks out poststroke survival

The heart rate of stroke survivors may give an indication of their long-term prognosis, report researchers.

3 Sep 2012

Diabetes prevention: an interview with Julian Baines, CEO of EKF Diagnostics

NICE public health guideline 38 ‘Preventing type 2 diabetes: Risk identification and interventions for individuals at high risk’.

From EKF Diagnostics 3 Sep 2012

FSU researchers achieve significant benchmarks in alpha-tropomyosin study

Florida State University researchers led by physics doctoral student Campion Loong have achieved significant benchmarks in a study of the human cardiac protein alpha-tropomyosin, which is an essential, molecular-level component that controls the heart's contraction on every beat.

3 Sep 2012

Study assesses post-coronary artery bypass graft surgery atrial fibrillation and long-term survival

Atrial fibrillation is a common complication of cardiac surgery, occurring in 10 percent to 40 percent of patients. Recent studies show it to be associated with poorer health following surgery and poorer long-term survival. Furthermore, development of atrial fibrillation after cardiac surgery leads to average additional health care costs of $15,000 to $20,000.

1 Sep 2012

TNF inhibitors best cardiac option for psoriasis patients

Use of tumor necrosis factor inhibitors is associated with a significantly reduced risk for myocardial infarction in psoriasis patients compared with use of other medications, report researchers.

31 Aug 2012

Researchers identify several genetic factors linked to C-reactive protein

African Americans have higher blood levels of a protein associated with increased heart-disease risk than European Americans, despite higher "good" HDL cholesterol and lower "bad" triglyceride levels. This contradictory observation now may be explained, in part, by a genetic variant identified in the first large-scale, genome-wide association study of this protein involving 12,000 African American and Hispanic American women.

31 Aug 2012

Healthy diets during infancy and early childhood can prevent obesity in future

Rats born to mothers fed high-fat diets but who get normal levels of fat in their diets right after birth avoid obesity and its related disorders as adults, according to new Johns Hopkins research.

31 Aug 2012

Janssen receives FDA Priority Review for ZYTIGA sNDA to treat mCRPC

Janssen Research & Development, LLC, announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for ZYTIGA (abiraterone acetate) administered in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy.

30 Aug 2012

EHRA White Book reports on current status of arrhythmia treatments in 54 ESC member countries

The analysis was conducted using five editions of the EHRA White Book, which is produced by the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC).

30 Aug 2012

Combination of POZEN’s PA32540 and clopidogrel results in greater antiplatelet effects

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced the presentation of Phase 1 data, at the European Society of Cardiologists 2012 Congress, from a study of PA32540, a novel coordinated-delivery tablet of enteric-coated (EC) aspirin (325 mg) and immediate-release (IR) omeprazole (40 mg).

30 Aug 2012

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Long-term cardiac impact of Japan quake revealed

Study evaluates prognostic utility of novel biomarkers of cardiovascular stress

Green tea chemical found to boost memory

Motor coordination in children with sedentary lifestyles: an interview with Dr. Luis Lopes

Lack of evidence to recommend routine screening for chronic kidney disease

Exposure to perfluorooctanoic acid appears to increase risk of CVD and peripheral arterial disease

Low blood pressure increases diabetes mortality risk

Heart rate marks out poststroke survival

Diabetes prevention: an interview with Julian Baines, CEO of EKF Diagnostics

FSU researchers achieve significant benchmarks in alpha-tropomyosin study

Study assesses post-coronary artery bypass graft surgery atrial fibrillation and long-term survival

TNF inhibitors best cardiac option for psoriasis patients

Researchers identify several genetic factors linked to C-reactive protein

Healthy diets during infancy and early childhood can prevent obesity in future

Janssen receives FDA Priority Review for ZYTIGA sNDA to treat mCRPC

EHRA White Book reports on current status of arrhythmia treatments in 54 ESC member countries

Combination of POZEN’s PA32540 and clopidogrel results in greater antiplatelet effects

Long-term cardiac impact of Japan quake revealed

Mortality risk similar for White vs Black diabetics

Study finds decline in 30-day mortality of acute myocardial infarction with improved treatment

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in